Feasibility of Intravaginal Artesunate as an Adjuvant HPV & Cervical Precancer Treatment Among Women Living With HIV in Kenya: Study Protocol for a Phase II Clinical Trial.

Sadana A, Omoto J, Sorgi K, Rahangdale L, Smith JS, Plesa M, Mungo C.

Open source

DOI: 10.1177/10732748251374418
Published: 2025-01-01
Container: Cancer Control
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/10732748251374418,
  title = {Feasibility of Intravaginal Artesunate as an Adjuvant HPV \&amp; Cervical Precancer Treatment Among Women Living With HIV in Kenya: Study Protocol for a Phase II Clinical Trial.},
  author = {Sadana A and  Omoto J and  Sorgi K and  Rahangdale L and  Smith JS and  Plesa M and  Mungo C.},
  year = {2025},
  journal = {Cancer Control},
  doi = {10.1177/10732748251374418},
  url = {https://doi.org/10.1177/10732748251374418}
}

RIS

TY  - JOUR
TI  - Feasibility of Intravaginal Artesunate as an Adjuvant HPV &amp; Cervical Precancer Treatment Among Women Living With HIV in Kenya: Study Protocol for a Phase II Clinical Trial.
AU  - Sadana A
AU  -  Omoto J
AU  -  Sorgi K
AU  -  Rahangdale L
AU  -  Smith JS
AU  -  Plesa M
AU  -  Mungo C.
PY  - 2025
JO  - Cancer Control
DO  - 10.1177/10732748251374418
UR  - https://doi.org/10.1177/10732748251374418
ER  -

APA

A, S., J, O., K, S., L, R., JS, S., M, P., & C., M. (2025). Feasibility of Intravaginal Artesunate as an Adjuvant HPV & Cervical Precancer Treatment Among Women Living With HIV in Kenya: Study Protocol for a Phase II Clinical Trial.. Cancer Control. https://doi.org/10.1177/10732748251374418

Source records

europe-pmc · retrieved 2026-09-25T21:56:17.140Z
doaj · retrieved 2026-09-25T21:56:17.145Z

Feasibility of Intravaginal Artesunate as an Adjuvant HPV &amp; Cervical Precancer Treatment Among Women Living With HIV in Kenya: Study Protocol for a Phase II Clinical Trial.

Credibility signals

Cite this work

BibTeX

RIS

APA

Source records

Feasibility of Intravaginal Artesunate as an Adjuvant HPV & Cervical Precancer Treatment Among Women Living With HIV in Kenya: Study Protocol for a Phase II Clinical Trial.